Sword Health Stock

swordhealth.comHealthcare / Healthcare providers & servicesFounded: 2014Funding to Date: $619.71MM

Sword Health, founded in 2014, is an online platform focused on preventing, managing, and treating pain through digital physical therapy at accessible costs. Sword’s platform combines their proprietary artificial intelligence with sensor technology delivering live feedback that can be shared with a therapist remotely.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for Sword Health, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Sword Health Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Sword Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
06/04/2024 Series E $30MM $xx.xx $3B Khosla Ventures
Price per Share
$xx.xx
Shares Outstanding
551,268
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Khosla Ventures
11/22/2021 Series D $163MM $xx.xx $1.81B Adq, Bond, Founders Fund, General Catalyst, Green Innovations, Khosla Ventures, Localglobe, Sapphire Ventures, Sozo Ventures, Transformation Capital, Willoughby Capital
Price per Share
$xx.xx
Shares Outstanding
4,486,366
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adq, Bond, Founders Fund, General Catalyst, Green Innovations, Khosla Ventures, Localglobe, Sapphire Ventures, Sozo Ventures, Transformation Capital, Willoughby Capital
06/30/2021 Series C $76.33MM $xx.xx $496.89MM Bond, Bpea, Founders Fund, General Catalyst, Green Innovations, Highmark Ventures, Khosla Ventures, Transformation Capital
Price per Share
$xx.xx
Shares Outstanding
7,055,533
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bond, Bpea, Founders Fund, General Catalyst, Green Innovations, Highmark Ventures, Khosla Ventures, Transformation Capital
02/01/2021 Series B $27.66MM $xx.xx $281.98MM Faber Ventures, Founders Fund, Green Innovations, Khosla Ventures, Sequoia Capital, Transformation Capital, Vesalius Biocapital
Price per Share
$xx.xx
Shares Outstanding
8,367,700
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Faber Ventures, Founders Fund, Green Innovations, Khosla Ventures, Sequoia Capital, Transformation Capital, Vesalius Biocapital
02/01/2021 Series B-1 $6.42MM $xx.xx $281.98MM Faber Ventures, Founders Fund, Green Innovations, Khosla Ventures, Sequoia Capital, Transformation Capital, Vesalius Biocapital
Price per Share
$xx.xx
Shares Outstanding
951,935
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Faber Ventures, Founders Fund, Green Innovations, Khosla Ventures, Sequoia Capital, Transformation Capital, Vesalius Biocapital
02/27/2020 Series A-2 $8.64MM $xx.xx $55.34MM Faber Ventures, Founders Fund, Green Innovations, Khosla Ventures, Lachy Groom, Vesalius Biocapital
Price per Share
$xx.xx
Shares Outstanding
4,925,320
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Faber Ventures, Founders Fund, Green Innovations, Khosla Ventures, Lachy Groom, Vesalius Biocapital
04/16/2019 Series A-3 $4,632.24 $xx.xx $33.99MM Khosla Ventures
Price per Share
$xx.xx
Shares Outstanding
10,666
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Khosla Ventures
04/16/2019 Series A-4 $4.95MM $xx.xx $33.99MM Khosla Ventures
Price per Share
$xx.xx
Shares Outstanding
4,570,894
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Khosla Ventures
04/16/2019 Series A-1 $7.85MM $xx.xx $33.99MM Khosla Ventures
Price per Share
$xx.xx
Shares Outstanding
6,267,887
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Khosla Ventures

Sword Health Investors Also Invested in These Private Companies

Leadership & Board

Leadership

Virgílio Bento Ph.D
Co-Founder, Chief Executive Officer & Chairman
Valentina Longo
Chief Financial Officer
Márcio Colunas
Co-Founder, Chief Technology Officer, CSO & Board Member
Jason Richards
Chief Information Security Officer & Vice President of Security & Information Security
Beth Stevens
Chief Legal Officer
Michael Krueger
Chief Marketing Officer
Kyle Spackman
Chief Commercial Officer

Board

Dave Guilmette
Sword
Todd Cozzens Ph.D
Transformation Capital

Sword Health stock FAQs

plusminus

Can you buy Sword Health stock?

As Sword Health is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Sword Health, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy Sword Health stock?

To invest in a private company like Sword Health through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Sword Health stock?

Yes, you may sell the Sword Health stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Sword Health stock?

If you hold private company shares of Sword Health – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Sword Health on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is Sword Health a public company?

No, Sword Health is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Sword Health’s stock price?

Sword Health is a privately held company and therefore does not have a public stock price. However, you may access Sword Health private market stock price with Forge Data.
plusminus

What is Sword Health’s stock ticker symbol?

Sword Health does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Sword Health News and Media Highlights

Sword Health raises $130M and its valuation soars to $3B

In a new funding round led by Khosla Ventures Sword Health raised $130 million.

Sword Health Strategy: Focusing on AI Ahead of a Potential IPO

Sword Health, a physical therapy start-up, is strategically focusing on artificial intelligence ahead of a potential IPO. The company aims to triple its AI team and is open to making acquisitions to spur growth. CEO Virgilio Bento plans to take the company public after it achieves profitability, which is expected in 2024.

How This Founder is Working to Free 2 Billion People from Pain

Growing up, Virgilio Bento watched his older brother suffer an accident and struggle to access the intensive physical therapy he needed to recover. Bento has since dedicated his career to solving pain for the two billion people around the globe who suffer each year. In 2015, he started Sword Health to free the world from pain and has helped thousands of people along the way.

European tech companies are leading the fight against debilitating and chronic pain

Aspect Biosystems and Novo Nordisk are collaborating on a $2.6 billion project to develop therapeutics for type 1 diabetes and obesity. The companies aim to create 3D, biologically functional tissues containing insulin-producing cells that can be implanted without the need for immunosuppressive drugs. The partnership will fund up to four products for the treatment of diabetes and/or obesity, with Aspect eligible to receive up to $650 million per project based on future milestones, plus royalties on product sales.
Browse Insights
Updated on: Dec 21, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.